Exceptional Advisors

In addition to the expert leadership team at Third Coast we have assembled a scientific advisory board, each with an unmatched track record in cancer research and treatment.


Brian Druker, M.D.
Director, Knight Cancer Institute at Oregon Health & Science University, Portland

Dr. Druker revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. 

Ruth O’Regan, M.D.
Division Head, Hematology/Oncology, UW Carbone Cancer Center, Madison, Wis.

Dr. O’Regan is an internationally recognized breast cancer researcher and was previously a professor of hematology and medical oncology at Emory University in Atlanta.

Claire Thom, PharmD

Dr. Thom recently retired from Astellas as senior vice president and therapeutic area head for oncology. Prior to Astellas, Dr. Thom spent 12 years with Takeda as senior vice president, portfolio management and drug development.

Sumati Murli, Ph.D.

Dr. Murli is the director of clinical research at Johns Hopkins in Baltimore; MD.  Previously Dr. Murli was Senior Director of oncology clinical operations at the University of Chicago and she has more than 16 years of experience in biological and clinical cancer research in both industrial and academic settings.